Wendremaire Maeva, Hadi Tarik, Lopez Tatiana E, Guy Julien, Neiers Fabrice, Garrido Carmen, Simon Emmanuel, Jaffal Zohra, Bernigal Virginie, Bardou Marc, Lirussi Frédéric
INSERM UMR 1231, Centre for Translational and Molecular Medicine, Dijon, France.
Université de Bourgogne, Dijon, France.
Am J Reprod Immunol. 2024 Dec;92(6):e70015. doi: 10.1111/aji.70015.
Preterm birth (PTB) remains the leading cause of neonatal morbidity and mortality. Identifying women at high risk of spontaneous preterm labor (PTL) is challenging due to limited efficient diagnostic markers. Since human parturition involves inflammatory immune processes, we hypothesized that phenotyping of maternal peripheral lymphocytes might predict PTL. Therefore, we aimed to explore the relationship between maternal lymphocyte subpopulations and labor onset characterized by delivery within 7 days of admission in women hospitalized for PTL between 24 and 34 weeks of gestation.
Lymphocyte subpopulations were obtained from peripheral blood samples and characterized by flow cytometry: activated and regulatory T cells, natural killer and B cells, and T1/T2/T17 lymphocytes. Data analysis was conducted retrospectively based on the delivery within 7 days of admission.
Among 167 women admitted for PTL, less than 10% delivered within 7 days post-admission. HLA-DR expression was significantly increased on CD4CD8, CD4CD8, and CD4CD8 lymphocytes in women who delivered within 7 days. Subset levels below 5% of CD4CD8HLA-DR lymphocytes and 20% of CD4CD8HLA-DR lymphocytes were associated with no probability of delivering within 7 days.
Our study suggests that combining these two consecutive markers allowed us to identify 57% of women hospitalized for PTL with no probability of delivering within 7 days while retaining patients who delivered within 7 days. If prospectively validated, these markers may be able to identify patients at high risk of PTB and avoid a significant number of unnecessary admissions and healthcare costs.
ANSM number: 2010-A00516-33; ClinicalTrials.gov identifier: NCT01340222.
早产仍然是新生儿发病和死亡的主要原因。由于有效的诊断标志物有限,识别有自发性早产风险的女性具有挑战性。由于人类分娩涉及炎症免疫过程,我们推测母体外周淋巴细胞的表型可能预测早产。因此,我们旨在探讨孕24至34周因早产住院的女性中,母体淋巴细胞亚群与入院后7天内分娩所表征的分娩开始之间的关系。
从外周血样本中获取淋巴细胞亚群,并通过流式细胞术进行表征:活化T细胞和调节性T细胞、自然杀伤细胞和B细胞以及T1/T2/T17淋巴细胞。基于入院后7天内的分娩情况进行回顾性数据分析。
在167名因早产入院的女性中,不到10%在入院后7天内分娩。在入院后7天内分娩的女性中,CD4CD8、CD4CD8和CD4CD8淋巴细胞上的HLA-DR表达显著增加。CD4CD8HLA-DR淋巴细胞亚群水平低于5%和CD4CD8HLA-DR淋巴细胞亚群水平低于20%与入院后7天内分娩的可能性无关。
我们的研究表明,结合这两个连续标志物使我们能够识别57%因早产住院且入院后7天内无分娩可能性的女性,同时保留了入院后7天内分娩的患者。如果经过前瞻性验证,这些标志物可能能够识别早产高危患者,并避免大量不必要的入院和医疗费用。
法国国家药品安全局编号:2010 - A00516 - 33;美国国立医学图书馆临床试验标识符:NCT01340222。